NICE rejects gene therapy for children with neurodegenerative disorder
July 9, 2021Medical Communications
NICE does not recommend gene therapy OTL-200 (also called Libmeldy and made by Orchard Therapeutics) for treating children with the …
FDA narrows guidance on controversial Alzheimer’s drug
July 9, 2021Medical Communications
A month after the approval of Biogen’s controversial new Alzheimer’s drug, Aduhelm, the FDA has narrowed its guidance on who …
Global genetic exome sequence analysis collaboration announced
July 9, 2021Medical Communications
AbbVie, Pfizer, and Biogen have announced the launch of the world’s largest browsable resource linking rare protein-coding genetic variants to …
Tech successful in harvesting cancer cells in brain metastases patients
July 9, 2021Medical Communications
The University Medical Centre Hamburg-Eppendorf has published results of new work undertaken in patients with brain metastasis using ANGLE’s cell …
Children “extremely low risk” from COVID study finds
July 9, 2021Medical Communications COVID-19, Vaccine
The overall risk of children becoming severely ill or dying from COVID-19 is extremely low, scientists from University College London, …
The pill to be sold over the counter for first time in UK history
July 8, 2021The contraceptive pill will be sold over the counter without prescription for the first time in UK history. The MHRA …
Exscientia receives $1.5 million Gates grant for Covid-19 therapy
July 8, 2021The Oxford-based drugs firm Exscientia has won a $1.5 million grant from the Bill & Melinda Gates Foundation to create …
Gyros Protein Technologies and Cygnus Technologies expand collaboration
July 8, 2021Gyros Protein has announced the next phase of its on-going collaboration with Cygnus Technologies alongside the introduction of a new …
New screening method set to speed up drug discovery in major diseases
July 8, 2021drug discovery
Scientists from the University of Birmingham and the University of Leicester have discovered a new screening method that can test …
WHO recommends Roche and Sanofi treatments to cut COVID-19 death risk
July 8, 2021The WHO has recommended using arthritis drugs Actemra from Roche and Kevzara from Sanofi with corticosteroids for COVID-19 patients. This …
Mass COVID testing reduces cases by a fifth study shows
July 7, 2021Research and Development COVID-19 testing, COVID-19. testing, lateral flow tests, liverpool
A pilot study conducted by the University of Liverpool has found that mass rapid testing reduced COVID-19 cases in Liverpool …
First ex vivo human skin platform investigating ISR launched
July 7, 2021Research and Development
Genoskin has announced the launch of ISR Platform, a novel pre-clinical toolbox designed to study injection site reactions (ISR) in …
Summer COVID cases set to reach 2 million with 10 million isolating
July 7, 2021Research and Development COVID-19, Lockdown, UK, Vaccine, government
Analysis from the Guardian has found that over two million people could contract COVID-19 this summer, which could therefore lead …
EU orders nearly 40 million more J&J COVID vaccines
July 7, 2021Research and Development
The EU has ordered nearly 40 million more doses of the J&J COVID-19 vaccines for European countries. This is despite …
Breakthrough heart failure drug meets primary endpoint
July 7, 2021Research and Development
The Phase III trial for empagliflozin, a treatment for patients with heart failure with preserved ejection fraction, has met its …
Pfizer’s COVID-19 vaccine efficacy falls to 64% in Israel
July 6, 2021Manufacturing and Production
Israel has reported a decrease to 64% in the effectiveness of the Pfizer-BioNTech COVID-19 vaccine in preventing infections and symptomatic …
UVC light found to inactivate COVID virus in study
July 6, 2021Manufacturing and Production COVID-19, clinical trials, computer simulations, skin
A new study has found that Ultraviolet C (UVC) emitting lamps are fast, effective, and safe at inactivating SARS-CoV-2, the …
Sosei and InveniAI to collaborate on AI-powered drug discovery
July 6, 2021Manufacturing and Production
Sosei Heptares and InveniAI have entered a multi-target AI-powered and GPCR-focused drug discovery collaboration. The two companies will combine InveniAI’s …
Novel cancer therapy kick starts clinical trials
July 6, 2021Manufacturing and Production oncology
The first patient has been dosed in Phase 1/2 trials investigating a new form of cancer therapy, gamma delta TCR …
MIMETAS and Roche to collaborate on drug development
July 6, 2021Manufacturing and Production
MIMETAS and Roche have entered into a collaboration to develop human disease models to characterise novel compounds in inflammatory bowel …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
